New Data Show TREMFYA® (guselkumab) Binds to Both Infla

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the first results of the in vitro MODIF-Y studies, supporting a...

Related Keywords

New York , United States , Japan , Portland , Oregon , United Kingdom , Rockefeller University , Horsham , Norfolk , Spring House , British Columbia , Canada , Americans , American , British , Jamesg Krueger , Scandj Rheumatol , D Martin Carter , Donvitot Creakyjoints , Dan Cua , Bridget Kimmel , Zismand Comorbidities , None Of The Janssen Pharmaceutical Companies , Drug Administration , Society For Investigative Dermatology , Janssen Research Development , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , Research Development , Exchange Commission , Companies Of Johnson , National Psoriasis Foundation , Johnson , Journal Of The American Academy Dermatology , Investigative Dermatology , Carter Professor , Clinical Investigation , Translational Science , Local Neutralization , Vice President , Plaque Psoriasis , Psoriatic Arthritis , Prescribing Information , Medication Guidefor , Pharmaceutical Companies , Infectious Diseases , Private Securities Litigation Reform Act , Janssen Research , Annual Report , Note Regarding Forward Looking , Quarterly Reports , Sci Rep , Inflammatory Mononuclear Phagocyte , T Cell Profiles , Psoriatic Skin , American Academy , Monoclonal Antibody Specific , Study Conducted , Active Psoriatic , Tissue Distribution , Healthy Participants , Patients With Psoriatic , Participants With Moderately , Severely Active Crohn , Severely Active Ulcerative Colitis , National Psoriasis , Accessed May , Painful Arthritis Symptom You Should Know , Sausage Finger Swelling You Should Know , Rambam Maimonides Med , About Psoriatic , Rheumatic Diseases , Immune Based Therapies , Janssen Pharmaceutical Companies Of Johnson Amp ,